Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRINITY: Romosozumab for Osteoporosis in Hemodialysis Patients
jRCT1041200081Recruiting
- Start
- Dec 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Randomised trial of romosozumab in osteoporosis (2 arms). Started Dec 2020; status: recruiting.
02
Drugs
romosozumab
03
Conditions
osteoporosis
Beyond the preview
Go deeper on jRCT1041200081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041200081.